Michael Drazer
@michaelwd
Physician-scientist @ the intersection of genetics, hematology/oncology, & patient care. Runner. Tweets are my own - no COI. Scholar: https://t.co/AST8hH0Uyk
ID:10056172
http://thedrazergroup.org 08-11-2007 05:01:15
4,6K Tweets
983 Followers
662 Following
Approximately two-thirds of approved drugs over the last decade had human genetics support for the mechanisms of action nature.com/articles/d4157… Nature Reviews Drug Discovery
Later today, Tadeusz Kubicki will address two significant questions on mass spectrometry-based assessment in MM patients – the role of MS in response assessment for pts without a high disease burden baseline and the optimal timing of MS assessment.
UChicagoCancerCenter University of Chicago Hematology/Oncology
From a Small Town in the Rust Belt, Dennis J. Slamon, MD, PhD, Plays a Big Role in Changing the Face of Breast Cancer Treatment ascopost.com/issues/novembe… #bcsm #breastcancer #oncology UCLA Health
The Leapfrog Group gave the University of Chicago Medical Center its 24th consecutive 'A' in patient safety, making it one of just 18 organizations nationwide to receive a straight “A” since the independent industry watchdog began its semiannual review. uchicagomedicine.org/forefront/news…
Drs. Deji Adegunsoye (Deji Adegunsoye, MD, PhD), Natalia Gonzales, and Yoav Gilad (@Y_Gilad) describe how iPSC models address particular challenges presented in various organ systems, and more. The University of Chicago The University of ChicagoMed
📑 bit.ly/3POYqRG